This report aims to provide a comprehensive presentation of the global market for Human Growth Hormone Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Growth Hormone Drugs. This report contains market size and forecasts of Human Growth Hormone Drugs in global, including the following market information:
Global Human Growth Hormone Drugs Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global Human Growth Hormone Drugs Market Sales, 2018-2023, 2024-2032, (K Pcs)
Global top five Human Growth Hormone Drugs companies in 2022 (%)
The global Human Growth Hormone Drugs market was valued at US$ 250 million in 2022 and is projected to reach US$ 328.6 million by 2029, at a CAGR of 4.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Norditropin Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Human Growth Hormone Drugs include Eli Lilly and Company (US), Ferring Holding SA (Switzerland), Genentech, Inc. (US), GeneScience Pharmaceuticals Co., Ltd. (China), Merck KgaA (Germany), Novo Nordisk A/S (Denmark), Pfizer, Inc. (US) and Sandoz International GmbH (Germany), etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Human Growth Hormone Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Growth Hormone Drugs Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Pcs)
Global Human Growth Hormone Drugs Market Segment Percentages, by Type, 2022 (%)
Norditropin
Genotropin
Humatrope
Saizen
Omnitrope - the Somatropin Biosimilar
Somatropin Biopartners
Global Human Growth Hormone Drugs Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Pcs)
Global Human Growth Hormone Drugs Market Segment Percentages, by Application, 2022 (%)
Prader-Willi Syndrome
Turner Syndrome
Short Stature Homeobox Gene
Small for Gestational Age
Chronic Renal Insufficiency
Short Bowel Syndrome
Global Human Growth Hormone Drugs Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Pcs)
Global Human Growth Hormone Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Growth Hormone Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Human Growth Hormone Drugs revenues share in global market, 2022 (%)
Key companies Human Growth Hormone Drugs sales in global market, 2018-2023 (Estimated), (K Pcs)
Key companies Human Growth Hormone Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Eli Lilly and Company (US)
Ferring Holding SA (Switzerland)
Genentech, Inc. (US)
GeneScience Pharmaceuticals Co., Ltd. (China)
Merck KgaA (Germany)
Novo Nordisk A/S (Denmark)
Pfizer, Inc. (US)
Sandoz International GmbH (Germany)
Outline of Major Chapters:
Chapter 1: Introduces the definition of Human Growth Hormone Drugs, market overview.
Chapter 2: Global Human Growth Hormone Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Human Growth Hormone Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Human Growth Hormone Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Human Growth Hormone Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Human Growth Hormone Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Growth Hormone Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Human Growth Hormone Drugs Overall Market Size
2.1 Global Human Growth Hormone Drugs Market Size: 2022 VS 2030
2.2 Global Human Growth Hormone Drugs Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Human Growth Hormone Drugs Sales: 2018-2030
3 Company Landscape
3.1 Top Human Growth Hormone Drugs Players in Global Market
3.2 Top Global Human Growth Hormone Drugs Companies Ranked by Revenue
3.3 Global Human Growth Hormone Drugs Revenue by Companies
3.4 Global Human Growth Hormone Drugs Sales by Companies
3.5 Global Human Growth Hormone Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Human Growth Hormone Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Human Growth Hormone Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Human Growth Hormone Drugs Players in Global Market
3.8.1 List of Global Tier 1 Human Growth Hormone Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Human Growth Hormone Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Human Growth Hormone Drugs Market Size Markets, 2022 & 2030
4.1.2 Norditropin
4.1.3 Genotropin
4.1.4 Humatrope
4.1.5 Saizen
4.1.6 Omnitrope - the Somatropin Biosimilar
4.1.7 Somatropin Biopartners
4.2 By Type - Global Human Growth Hormone Drugs Revenue & Forecasts
4.2.1 By Type - Global Human Growth Hormone Drugs Revenue, 2018-2023
4.2.2 By Type - Global Human Growth Hormone Drugs Revenue, 2024-2030
4.2.3 By Type - Global Human Growth Hormone Drugs Revenue Market Share, 2018-2030
4.3 By Type - Global Human Growth Hormone Drugs Sales & Forecasts
4.3.1 By Type - Global Human Growth Hormone Drugs Sales, 2018-2023
4.3.2 By Type - Global Human Growth Hormone Drugs Sales, 2024-2030
4.3.3 By Type - Global Human Growth Hormone Drugs Sales Market Share, 2018-2030
4.4 By Type - Global Human Growth Hormone Drugs Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Human Growth Hormone Drugs Market Size, 2022 & 2030
5.1.2 Prader-Willi Syndrome
5.1.3 Turner Syndrome
5.1.4 Short Stature Homeobox Gene
5.1.5 Small for Gestational Age
5.1.6 Chronic Renal Insufficiency
5.1.7 Short Bowel Syndrome
5.2 By Application - Global Human Growth Hormone Drugs Revenue & Forecasts
5.2.1 By Application - Global Human Growth Hormone Drugs Revenue, 2018-2023
5.2.2 By Application - Global Human Growth Hormone Drugs Revenue, 2024-2030
5.2.3 By Application - Global Human Growth Hormone Drugs Revenue Market Share, 2018-2030
5.3 By Application - Global Human Growth Hormone Drugs Sales & Forecasts
5.3.1 By Application - Global Human Growth Hormone Drugs Sales, 2018-2023
5.3.2 By Application - Global Human Growth Hormone Drugs Sales, 2024-2030
5.3.3 By Application - Global Human Growth Hormone Drugs Sales Market Share, 2018-2030
5.4 By Application - Global Human Growth Hormone Drugs Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Human Growth Hormone Drugs Market Size, 2022 & 2030
6.2 By Region - Global Human Growth Hormone Drugs Revenue & Forecasts
6.2.1 By Region - Global Human Growth Hormone Drugs Revenue, 2018-2023
6.2.2 By Region - Global Human Growth Hormone Drugs Revenue, 2024-2030
6.2.3 By Region - Global Human Growth Hormone Drugs Revenue Market Share, 2018-2030
6.3 By Region - Global Human Growth Hormone Drugs Sales & Forecasts
6.3.1 By Region - Global Human Growth Hormone Drugs Sales, 2018-2023
6.3.2 By Region - Global Human Growth Hormone Drugs Sales, 2024-2030
6.3.3 By Region - Global Human Growth Hormone Drugs Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Human Growth Hormone Drugs Revenue, 2018-2030
6.4.2 By Country - North America Human Growth Hormone Drugs Sales, 2018-2030
6.4.3 US Human Growth Hormone Drugs Market Size, 2018-2030
6.4.4 Canada Human Growth Hormone Drugs Market Size, 2018-2030
6.4.5 Mexico Human Growth Hormone Drugs Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Human Growth Hormone Drugs Revenue, 2018-2030
6.5.2 By Country - Europe Human Growth Hormone Drugs Sales, 2018-2030
6.5.3 Germany Human Growth Hormone Drugs Market Size, 2018-2030
6.5.4 France Human Growth Hormone Drugs Market Size, 2018-2030
6.5.5 U.K. Human Growth Hormone Drugs Market Size, 2018-2030
6.5.6 Italy Human Growth Hormone Drugs Market Size, 2018-2030
6.5.7 Russia Human Growth Hormone Drugs Market Size, 2018-2030
6.5.8 Nordic Countries Human Growth Hormone Drugs Market Size, 2018-2030
6.5.9 Benelux Human Growth Hormone Drugs Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Human Growth Hormone Drugs Revenue, 2018-2030
6.6.2 By Region - Asia Human Growth Hormone Drugs Sales, 2018-2030
6.6.3 China Human Growth Hormone Drugs Market Size, 2018-2030
6.6.4 Japan Human Growth Hormone Drugs Market Size, 2018-2030
6.6.5 South Korea Human Growth Hormone Drugs Market Size, 2018-2030
6.6.6 Southeast Asia Human Growth Hormone Drugs Market Size, 2018-2030
6.6.7 India Human Growth Hormone Drugs Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Human Growth Hormone Drugs Revenue, 2018-2030
6.7.2 By Country - South America Human Growth Hormone Drugs Sales, 2018-2030
6.7.3 Brazil Human Growth Hormone Drugs Market Size, 2018-2030
6.7.4 Argentina Human Growth Hormone Drugs Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Human Growth Hormone Drugs Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Human Growth Hormone Drugs Sales, 2018-2030
6.8.3 Turkey Human Growth Hormone Drugs Market Size, 2018-2030
6.8.4 Israel Human Growth Hormone Drugs Market Size, 2018-2030
6.8.5 Saudi Arabia Human Growth Hormone Drugs Market Size, 2018-2030
6.8.6 UAE Human Growth Hormone Drugs Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Eli Lilly and Company (US)
7.1.1 Eli Lilly and Company (US) Company Summary
7.1.2 Eli Lilly and Company (US) Business Overview
7.1.3 Eli Lilly and Company (US) Human Growth Hormone Drugs Major Product Offerings
7.1.4 Eli Lilly and Company (US) Human Growth Hormone Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Eli Lilly and Company (US) Key News & Latest Developments
7.2 Ferring Holding SA (Switzerland)
7.2.1 Ferring Holding SA (Switzerland) Company Summary
7.2.2 Ferring Holding SA (Switzerland) Business Overview
7.2.3 Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Major Product Offerings
7.2.4 Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Ferring Holding SA (Switzerland) Key News & Latest Developments
7.3 Genentech, Inc. (US)
7.3.1 Genentech, Inc. (US) Company Summary
7.3.2 Genentech, Inc. (US) Business Overview
7.3.3 Genentech, Inc. (US) Human Growth Hormone Drugs Major Product Offerings
7.3.4 Genentech, Inc. (US) Human Growth Hormone Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Genentech, Inc. (US) Key News & Latest Developments
7.4 GeneScience Pharmaceuticals Co., Ltd. (China)
7.4.1 GeneScience Pharmaceuticals Co., Ltd. (China) Company Summary
7.4.2 GeneScience Pharmaceuticals Co., Ltd. (China) Business Overview
7.4.3 GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Major Product Offerings
7.4.4 GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Sales and Revenue in Global (2018-2023)
7.4.5 GeneScience Pharmaceuticals Co., Ltd. (China) Key News & Latest Developments
7.5 Merck KgaA (Germany)
7.5.1 Merck KgaA (Germany) Company Summary
7.5.2 Merck KgaA (Germany) Business Overview
7.5.3 Merck KgaA (Germany) Human Growth Hormone Drugs Major Product Offerings
7.5.4 Merck KgaA (Germany) Human Growth Hormone Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Merck KgaA (Germany) Key News & Latest Developments
7.6 Novo Nordisk A/S (Denmark)
7.6.1 Novo Nordisk A/S (Denmark) Company Summary
7.6.2 Novo Nordisk A/S (Denmark) Business Overview
7.6.3 Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Major Product Offerings
7.6.4 Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Novo Nordisk A/S (Denmark) Key News & Latest Developments
7.7 Pfizer, Inc. (US)
7.7.1 Pfizer, Inc. (US) Company Summary
7.7.2 Pfizer, Inc. (US) Business Overview
7.7.3 Pfizer, Inc. (US) Human Growth Hormone Drugs Major Product Offerings
7.7.4 Pfizer, Inc. (US) Human Growth Hormone Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Pfizer, Inc. (US) Key News & Latest Developments
7.8 Sandoz International GmbH (Germany)
7.8.1 Sandoz International GmbH (Germany) Company Summary
7.8.2 Sandoz International GmbH (Germany) Business Overview
7.8.3 Sandoz International GmbH (Germany) Human Growth Hormone Drugs Major Product Offerings
7.8.4 Sandoz International GmbH (Germany) Human Growth Hormone Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Sandoz International GmbH (Germany) Key News & Latest Developments
8 Global Human Growth Hormone Drugs Production Capacity, Analysis
8.1 Global Human Growth Hormone Drugs Production Capacity, 2018-2030
8.2 Human Growth Hormone Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Human Growth Hormone Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Human Growth Hormone Drugs Supply Chain Analysis
10.1 Human Growth Hormone Drugs Industry Value Chain
10.2 Human Growth Hormone Drugs Upstream Market
10.3 Human Growth Hormone Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Human Growth Hormone Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Human Growth Hormone Drugs in Global Market
Table 2. Top Human Growth Hormone Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Human Growth Hormone Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Human Growth Hormone Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Human Growth Hormone Drugs Sales by Companies, (K Pcs), 2018-2023
Table 6. Global Human Growth Hormone Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Human Growth Hormone Drugs Price (2018-2023) & (USD/Pcs)
Table 8. Global Manufacturers Human Growth Hormone Drugs Product Type
Table 9. List of Global Tier 1 Human Growth Hormone Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Human Growth Hormone Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Human Growth Hormone Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Human Growth Hormone Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Human Growth Hormone Drugs Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Human Growth Hormone Drugs Sales (K Pcs), 2018-2023
Table 15. By Type - Global Human Growth Hormone Drugs Sales (K Pcs), 2024-2030
Table 16. By Application ? Global Human Growth Hormone Drugs Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Human Growth Hormone Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Human Growth Hormone Drugs Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Human Growth Hormone Drugs Sales (K Pcs), 2018-2023
Table 20. By Application - Global Human Growth Hormone Drugs Sales (K Pcs), 2024-2030
Table 21. By Region ? Global Human Growth Hormone Drugs Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Human Growth Hormone Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Human Growth Hormone Drugs Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Human Growth Hormone Drugs Sales (K Pcs), 2018-2023
Table 25. By Region - Global Human Growth Hormone Drugs Sales (K Pcs), 2024-2030
Table 26. By Country - North America Human Growth Hormone Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Human Growth Hormone Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Human Growth Hormone Drugs Sales, (K Pcs), 2018-2023
Table 29. By Country - North America Human Growth Hormone Drugs Sales, (K Pcs), 2024-2030
Table 30. By Country - Europe Human Growth Hormone Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Human Growth Hormone Drugs Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Human Growth Hormone Drugs Sales, (K Pcs), 2018-2023
Table 33. By Country - Europe Human Growth Hormone Drugs Sales, (K Pcs), 2024-2030
Table 34. By Region - Asia Human Growth Hormone Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Human Growth Hormone Drugs Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Human Growth Hormone Drugs Sales, (K Pcs), 2018-2023
Table 37. By Region - Asia Human Growth Hormone Drugs Sales, (K Pcs), 2024-2030
Table 38. By Country - South America Human Growth Hormone Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Human Growth Hormone Drugs Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Human Growth Hormone Drugs Sales, (K Pcs), 2018-2023
Table 41. By Country - South America Human Growth Hormone Drugs Sales, (K Pcs), 2024-2030
Table 42. By Country - Middle East & Africa Human Growth Hormone Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Human Growth Hormone Drugs Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Human Growth Hormone Drugs Sales, (K Pcs), 2018-2023
Table 45. By Country - Middle East & Africa Human Growth Hormone Drugs Sales, (K Pcs), 2024-2030
Table 46. Eli Lilly and Company (US) Company Summary
Table 47. Eli Lilly and Company (US) Human Growth Hormone Drugs Product Offerings
Table 48. Eli Lilly and Company (US) Human Growth Hormone Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 49. Eli Lilly and Company (US) Key News & Latest Developments
Table 50. Ferring Holding SA (Switzerland) Company Summary
Table 51. Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Product Offerings
Table 52. Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 53. Ferring Holding SA (Switzerland) Key News & Latest Developments
Table 54. Genentech, Inc. (US) Company Summary
Table 55. Genentech, Inc. (US) Human Growth Hormone Drugs Product Offerings
Table 56. Genentech, Inc. (US) Human Growth Hormone Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 57. Genentech, Inc. (US) Key News & Latest Developments
Table 58. GeneScience Pharmaceuticals Co., Ltd. (China) Company Summary
Table 59. GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Product Offerings
Table 60. GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 61. GeneScience Pharmaceuticals Co., Ltd. (China) Key News & Latest Developments
Table 62. Merck KgaA (Germany) Company Summary
Table 63. Merck KgaA (Germany) Human Growth Hormone Drugs Product Offerings
Table 64. Merck KgaA (Germany) Human Growth Hormone Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 65. Merck KgaA (Germany) Key News & Latest Developments
Table 66. Novo Nordisk A/S (Denmark) Company Summary
Table 67. Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Product Offerings
Table 68. Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 69. Novo Nordisk A/S (Denmark) Key News & Latest Developments
Table 70. Pfizer, Inc. (US) Company Summary
Table 71. Pfizer, Inc. (US) Human Growth Hormone Drugs Product Offerings
Table 72. Pfizer, Inc. (US) Human Growth Hormone Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 73. Pfizer, Inc. (US) Key News & Latest Developments
Table 74. Sandoz International GmbH (Germany) Company Summary
Table 75. Sandoz International GmbH (Germany) Human Growth Hormone Drugs Product Offerings
Table 76. Sandoz International GmbH (Germany) Human Growth Hormone Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 77. Sandoz International GmbH (Germany) Key News & Latest Developments
Table 78. Human Growth Hormone Drugs Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2021-2023 (K Pcs)
Table 79. Global Human Growth Hormone Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 80. Global Human Growth Hormone Drugs Production by Region, 2018-2023 (K Pcs)
Table 81. Global Human Growth Hormone Drugs Production by Region, 2024-2030 (K Pcs)
Table 82. Human Growth Hormone Drugs Market Opportunities & Trends in Global Market
Table 83. Human Growth Hormone Drugs Market Drivers in Global Market
Table 84. Human Growth Hormone Drugs Market Restraints in Global Market
Table 85. Human Growth Hormone Drugs Raw Materials
Table 86. Human Growth Hormone Drugs Raw Materials Suppliers in Global Market
Table 87. Typical Human Growth Hormone Drugs Downstream
Table 88. Human Growth Hormone Drugs Downstream Clients in Global Market
Table 89. Human Growth Hormone Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Human Growth Hormone Drugs Segment by Type in 2022
Figure 2. Human Growth Hormone Drugs Segment by Application in 2022
Figure 3. Global Human Growth Hormone Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Human Growth Hormone Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Human Growth Hormone Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. Human Growth Hormone Drugs Sales in Global Market: 2018-2030 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Human Growth Hormone Drugs Revenue in 2022
Figure 9. By Type - Global Human Growth Hormone Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Human Growth Hormone Drugs Revenue Market Share, 2018-2030
Figure 11. By Type - Global Human Growth Hormone Drugs Sales Market Share, 2018-2030
Figure 12. By Type - Global Human Growth Hormone Drugs Price (USD/Pcs), 2018-2030
Figure 13. By Application - Global Human Growth Hormone Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Human Growth Hormone Drugs Revenue Market Share, 2018-2030
Figure 15. By Application - Global Human Growth Hormone Drugs Sales Market Share, 2018-2030
Figure 16. By Application - Global Human Growth Hormone Drugs Price (USD/Pcs), 2018-2030
Figure 17. By Region - Global Human Growth Hormone Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Human Growth Hormone Drugs Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Human Growth Hormone Drugs Revenue Market Share, 2018-2030
Figure 20. By Region - Global Human Growth Hormone Drugs Sales Market Share, 2018-2030
Figure 21. By Country - North America Human Growth Hormone Drugs Revenue Market Share, 2018-2030
Figure 22. By Country - North America Human Growth Hormone Drugs Sales Market Share, 2018-2030
Figure 23. US Human Growth Hormone Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Human Growth Hormone Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Human Growth Hormone Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Human Growth Hormone Drugs Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Human Growth Hormone Drugs Sales Market Share, 2018-2030
Figure 28. Germany Human Growth Hormone Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. France Human Growth Hormone Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Human Growth Hormone Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Human Growth Hormone Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Human Growth Hormone Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Human Growth Hormone Drugs Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Human Growth Hormone Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Human Growth Hormone Drugs Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Human Growth Hormone Drugs Sales Market Share, 2018-2030
Figure 37. China Human Growth Hormone Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Human Growth Hormone Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Human Growth Hormone Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Human Growth Hormone Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. India Human Growth Hormone Drugs Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Human Growth Hormone Drugs Revenue Market Share, 2018-2030
Figure 43. By Country - South America Human Growth Hormone Drugs Sales Market Share, 2018-2030
Figure 44. Brazil Human Growth Hormone Drugs Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Human Growth Hormone Drugs Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Human Growth Hormone Drugs Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Human Growth Hormone Drugs Sales Market Share, 2018-2030
Figure 48. Turkey Human Growth Hormone Drugs Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Human Growth Hormone Drugs Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Human Growth Hormone Drugs Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Human Growth Hormone Drugs Revenue, (US$, Mn), 2018-2030
Figure 52. Global Human Growth Hormone Drugs Production Capacity (K Pcs), 2018-2030
Figure 53. The Percentage of Production Human Growth Hormone Drugs by Region, 2022 VS 2030
Figure 54. Human Growth Hormone Drugs Industry Value Chain
Figure 55. Marketing Channels
